Morich Frank — SEC insider filings

SEC reporting owner CIK 1748615. 14 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2021-01-06 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cue Biopharma, Inc. (CUE)Director71 leg · 28,000 sh · $105,000—6
Perspective Therapeutics, Inc. (CATX)Director72 legs · 30,000 sh · $29,002—6

Insider filings — Morich Frank

FiledFormIssuerReported transactionsSource
2026-11-174Perspective Therapeutics, Inc. (CATX)Purchase (P): 15,000 @ $0.94EDGAR
2026-11-164Perspective Therapeutics, Inc. (CATX)Purchase (P): 15,000 @ $1.00EDGAR
2026-03-044Perspective Therapeutics, Inc. (CATX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2026-01-064Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2025-03-054Perspective Therapeutics, Inc. (CATX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-01-034Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2024-06-244Perspective Therapeutics, Inc. (CATX)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2024-01-044Cue Biopharma, Inc. (CUE)Grant/award (A): 24,400 (derivative) @ $0EDGAR
2023-12-144Perspective Therapeutics, Inc. (CATX)Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-02-234Perspective Therapeutics, Inc. (ISR)Grant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-01-054Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-05-314Cue Biopharma, Inc. (CUE)Purchase (P): 28,000 @ $3.75EDGAR
2022-01-054Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-01-064Cue Biopharma, Inc. (CUE)Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1748615 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs